EP Patent

EP3698785A1 — Compositions comprising a cannabinoid receptor binding ligand

Assigned to Novaliq GmbH · Expires 2020-08-26 · 6y expired

What this patent protects

The present invention provides a pharmaceutical composition comprising:a) a therapeutically effective amount of at least one cannabinoid receptor binding ligand, andb) a liquid vehicle comprising at least one semifluorinated alkane;as well as the use of such pharmaceutical compos…

USPTO Abstract

The present invention provides a pharmaceutical composition comprising:a) a therapeutically effective amount of at least one cannabinoid receptor binding ligand, andb) a liquid vehicle comprising at least one semifluorinated alkane;as well as the use of such pharmaceutical compositions as a medicament.

Drugs covered by this patent

Patent Metadata

Patent number
EP3698785A1
Jurisdiction
EP
Classification
—
Expires
2020-08-26
Drug substance claim
No
Drug product claim
No
Assignee
Novaliq GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.